Cochrane Abstracts
Combination versus sequential single agent chemotherapy for metastatic breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Combination Versus Sequential Single Agent Chemotherapy for Metastatic Breast Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439626/all/Combination_versus_sequential_single_agent_chemotherapy_for_metastatic_breast_cancer.
Combination versus sequential single agent chemotherapy for metastatic breast cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439626/all/Combination_versus_sequential_single_agent_chemotherapy_for_metastatic_breast_cancer. Accessed March 26, 2025.
Combination versus sequential single agent chemotherapy for metastatic breast cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439626/all/Combination_versus_sequential_single_agent_chemotherapy_for_metastatic_breast_cancer
Combination Versus Sequential Single Agent Chemotherapy for Metastatic Breast Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439626/all/Combination_versus_sequential_single_agent_chemotherapy_for_metastatic_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combination versus sequential single agent chemotherapy for metastatic breast cancer
ID - 439626
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439626/all/Combination_versus_sequential_single_agent_chemotherapy_for_metastatic_breast_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
